Degradation of insulin by human fibroblasts: effects of inhibitors of pinocytosis and lysosomal activity.
The role of the pinosome-lysosome pathway in the degradation of 125I-labelled bovine insulin by cultured human fibroblasts was examined by comparing the effects of various known inhibitors of pinocytosis and lysosomal degradation on the uptake and degradation of 125I-labelled polyvinylpyrrolidone, formaldehyde-denatured bovine serum albumin and bovine insulin by these cells. Fibroblasts incubated with polyvinylpyrrolidone steadily accumulate this substrate, whereas incubations with insulin or denatured albumin led to the progressive appearance in the culture medium of [125I]iodotyrosine. Inhibitors of pinocytosis (bacitracin, colchicine and monensin), metabolic inhibitors (2,4-dinitrophenol and NaF), lysosomotropic agents (chloroquine and NH4Cl) and an inhibitor of cysteine-proteinases (leupeptin) decreased the rate of uptake of polyvinylpyrrolidone and denatured albumin very similarly, but only bacitracin had an effect on the processing of insulin. Chloroquine, NH4Cl and leupeptin strongly inhibited the digestion of denatured albumin, but not of insulin. The different responses to the modifiers, with polyvinylpyrrolidone and denatured albumin on the one hand and insulin on the other, suggest that insulin degradation can occur by a non-lysosomal pathway. The very strong inhibitory effect of bacitracin on insulin processing by fibroblasts may point to an important role of plasma membrane proteinases in insulin degradation.
D019297:2,4-Dinitrophenol; D000643:Ammonium Chloride / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001692:Biological Transport; D002478:Cells, Cultured; D004140:Dinitrophenols / Q000494:pharmacology; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000031:analogs & derivatives* / Q000378:metabolism; D007457:Iodine Radioisotopes; D007700:Kinetics; D007976:Leupeptins / Q000494:pharmacology; D008247:Lysosomes / Q000187:drug effects / Q000378:metabolism*; D010873:Pinocytosis / Q000187:drug effects*; D011206:Povidone-Iodine / Q000378:metabolism; D012867:Skin / Q000378:metabolism; D012969:Sodium Fluoride / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D004140:Dinitrophenols; D007328:Insulin; D007457:Iodine Radioisotopes; D007976:Leupeptins; C008147:insulin, iodo-; D000643:Ammonium Chloride; D011206:Povidone-Iodine; D012969:Sodium Fluoride; C032854:leupeptin; D019297:2,4-Dinitrophenol